This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 668303.
In the next five years, PERFORM will develop a comprehensive management plan for febrile patients, capable of being implemented across different health-care systems in Europe, linking sophisticated new genomic and proteomic approaches to clinical phenotyping.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 668303.